Rutgers Global Health Institute awards Global Health Seed Grants to faculty conducting collaborative, interdisciplinary activities that address health inequities in New Jersey and around the world. With these grants, we aim to help faculty pursue new ideas and seed...
An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck MRK -0.74% & Co. and partner Ridgeback Biotherapeutics LP. The panel, known as the...
NEJM Catalyst Innovations in Care Delivery The health inequities revealed by the Covid-19 pandemic, along with heightened awareness of racial justice issues, present opportunities for leaders, especially at community-based health centers, to engage with, listen to,...
With the spread of the COVID-19 Omicron variant, investors across the country have seen substantial hits to their portfolios. Richard Michelfelder, a clinical associate professor in the Rutgers–Camden School of Business whose research focuses on regulation, utility...
